Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Sarcelles, France Clinical Trials

A listing of Sarcelles, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (788) clinical trials

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

The purpose of the study is to test the effectiveness (how well the drug works), safety, and tolerability of the investigational drug called NKTR-214, when combined with nivolumab versus nivolumab given alone in participants with previously untreated melanoma skin cancer that is either unable to be surgically removed or has ...

Phase

9.8 miles

Learn More »

A Post-Authorisation Non-Interventional Observational of Patients in France With Primary Biliary Cholangitis Treated With Obeticholic Acid in Real Life

This is a non-interventional, multi-site, ambispective, national follow-up study of patients with Primary Biliary Cholangitis who started Ocaliva treatment between October 1st, 2016 and December 31, 2017. This represents approximately 150 patients to date, who are therefore the first patients to have received treatment with Ocaliva in France outside of ...

Phase N/A

9.8 miles

Learn More »

A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

The purpose of this study is to determine whether nivolumab plus ipilimumab or nivolumab alone is effective and safe in the treatment of solid tumors with High Tumor Mutational Burden (TMB-H)

Phase

9.8 miles

Learn More »

Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714

The first dose of ocrelizumab will be administered as two 300-mg IV infusions (600 mg total) in 250 mL 0.9% sodium chloride each separated by 14 days (i.e., Days 1 and 15), followed by one 600-mg IV infusion in 500 mL 0.9% sodium chloride every subsequent doses (i.e., every 24 ...

Phase

9.8 miles

Learn More »

Can Nephrocheck Predict the Reversibility of Early Acute Kidney Injury During Septic Shock?

Patients with septic shock in the intensive care unit have an elevated risk of developing acute kidney injury (AKI). AKI is an independent factor for mortality. Interventions that limit the worsening of renal function might have an impact on the mortality rate in these patients. Given the absence of validated ...

Phase N/A

9.8 miles

Learn More »

Study to Evaluate Two Diagnostic Strategies for the Treatment of Severe Community Acquired Pneumonia (SCAP)

Type of study randomized multicentric controlled open study Number of patients: 200 patients (100 patients in each group)admitted in ICU for SCAP - Number of center : 5 - Clinical strategies under evaluation : - Group A: semi-invasive strategy: FOB within 24 hours after ICU admission - Group B: non-invasive ...

Phase N/A

9.99 miles

Learn More »

HIV Patients Cohort

Since the arrival of highly active tritherapies, HIV infection became mainly an ambulatory chronic pathology centred on a long term care taking into account the complication of long-term treatment as well as the arisen of new problem bound to a prolonged survival and ageing. So the care is more and ...

Phase N/A

9.99 miles

Learn More »

Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide

An excess suicide-related morbidity is observed among young people in the Picardie region, as reflected by the > 100% occupation rate of the Amiens University Hospital Adolescent Medicine Unit. New approaches have been proposed to these problems that have led us to reorganize our diagnostic practices: 1) more precise characterization ...

Phase N/A

9.99 miles

Learn More »